These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 23719722)

  • 41. Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
    Geijselaers SLC; Aalten P; Ramakers IHGB; De Deyn PP; Heijboer AC; Koek HL; OldeRikkert MGM; Papma JM; Reesink FE; Smits LL; Stehouwer CDA; Teunissen CE; Verhey FRJ; van der Flier WM; Biessels GJ;
    J Alzheimers Dis; 2018; 61(1):309-320. PubMed ID: 29154275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.
    Adler BL; Yarchoan M; Hwang HM; Louneva N; Blair JA; Palm R; Smith MA; Lee HG; Arnold SE; Casadesus G
    Neurobiol Aging; 2014 Apr; 35(4):793-801. PubMed ID: 24239383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.
    Mustapic M; Tran J; Craft S; Kapogiannis D
    J Alzheimers Dis; 2019; 69(2):489-498. PubMed ID: 30958348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer's disease neuropathology.
    Yang JJ
    Acta Neurol Belg; 2022 Oct; 122(5):1135-1142. PubMed ID: 35482277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Dhamoon MS; Noble JM; Craft S
    Neurology; 2009 Jan; 72(3):292-3; author reply 293-4. PubMed ID: 19153380
    [No Abstract]   [Full Text] [Related]  

  • 48. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease.
    Robinson A; Lubitz I; Atrakchi-Baranes D; Licht-Murava A; Katsel P; Leroith D; Liraz-Zaltsman S; Haroutunian V; Beeri MS
    J Mol Neurosci; 2019 Apr; 67(4):504-510. PubMed ID: 30635783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.
    Talbot K; Wang HY
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S12-25. PubMed ID: 24529520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition.
    Salameh TS; Bullock KM; Hujoel IA; Niehoff ML; Wolden-Hanson T; Kim J; Morley JE; Farr SA; Banks WA
    J Alzheimers Dis; 2015; 47(3):715-28. PubMed ID: 26401706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Djupesland PG
    Neurology; 2008 Sep; 71(11):864; author reply 864. PubMed ID: 18779519
    [No Abstract]   [Full Text] [Related]  

  • 52. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial: Siegfried Hoyer's concept of Alzheimer pathophysiology.
    Frölich L; Müller WE; Riederer P
    J Neural Transm (Vienna); 2015 Apr; 122(4):495-7. PubMed ID: 25616721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant insulin signaling in Alzheimer's disease: current knowledge.
    Bedse G; Di Domenico F; Serviddio G; Cassano T
    Front Neurosci; 2015; 9():204. PubMed ID: 26136647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.
    de la Monte SM
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1699-709. PubMed ID: 24215447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How does brain insulin resistance develop in Alzheimer's disease?
    De Felice FG; Lourenco MV; Ferreira ST
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S26-32. PubMed ID: 24529521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition.
    Rhea EM; Humann SR; Nirkhe S; Farr SA; Morley JE; Banks WA
    J Alzheimers Dis; 2017; 57(1):241-252. PubMed ID: 28222522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin to treat Alzheimer's disease: just follow your nose?
    Schiöth HB; Frey WH; Brooks SJ; Benedict C
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):17-20. PubMed ID: 22142155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. S14G-humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse.
    Han K; Jia N; Zhong Y; Shang X
    J Cell Biochem; 2018 Apr; 119(4):3111-3117. PubMed ID: 29058763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.